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Abstract
Background: Knowledge about the prevalence and consequences of osteoarthritis (OA) in the Norwegian
population is limited. This study has been designed to gain a greater understanding of musculoskeletal pain in the
general population with a focus on clinically and radiologically confirmed OA, as well as risk factors, consequences,
and management of OA.
Methods/Design: The Musculoskeletal pain in Ullensaker STudy (MUST) has been designed as an observational
study comprising a population-based postal survey and a comprehensive clinical examination of a sub-sample
with self-reported OA (MUST OA cohort). All inhabitants in Ullensaker municipality, Norway, aged 40 to 79 years
receive the initial population-based postal survey questionnaire with questions about life style, general health,
musculoskeletal pain, self-reported OA, comorbidities, health care utilisation, medication use, and functional ability.
Participants who self-report OA in their hip, knee and/or hand joints are asked to attend a comprehensive clinical
examination at Diakonhjemmet Hospital, Oslo, including a comprehensive medical examination, performance-based
functional tests, different imaging modalities, cardiovascular assessment, blood and urine samples, and a number of
patient-reported questionnaires including five OA disease specific instruments. Data will be merged with six
national data registries. A subsample of those who receive the questionnaire has previously participated in postal
surveys conducted in 1990, 1994, and 2004 with data on musculoskeletal pain and functional ability in addition to
demographic characteristics and a number of health related factors. This subsample constitutes a population based
cohort with 20 years follow-up.
Discussion: This protocol describes the design of an observational population-based study that will involve the
collection of data from a postal survey on musculoskeletal pain, and a comprehensive clinical examination on those
with self-reported hand, hip and/or knee OA. These data, in addition to data from national registries, will provide
unique insights into clinically and radiologically confirmed OA with respect to risk factors, consequences, and
management.
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Background
Osteoarthritis (OA) is currently the most prevalent joint
disease and is one of the core diseases in the Bone and
Joint Decade 2011-2020 [1]. It can occur in any joint,
but is most commonly seen in selected joints of the
hand, spine, and lower limb. Clinically, OA is characte-
rised by joint pain, crepitus, swelling, stiffness, restricted
range of motion, fatigue, and functional limitations. OA
is one of the leading causes of pain and disability for the
adult population worldwide [2] and may have conside-
rable personal and societal consequences in relation to
health problems [3], work disability [4], and economical
costs [5-7]. Recently, sequela of the OA disease was de-
fined as one of the major contributors to years lived in
less than ideal health (years lived with disability (YLDs))
[8]. The burden of OA is better described for the knee
and hip, than for the hand joints and generalised OA [9].
OA is strongly age-related - it is uncommon before
the age of 40, but the prevalence rises rapidly with age
thereafter. Women are affected more frequently among
those aged > 45 years [10], and the gender difference is
most prominent for hand and knee OA [2]. Prevalence
estimates vary, as the estimate is dependent on the joint
of interest, the method of assessment, and the disease
definition used [11]. In a US cohort of individuals at
least 45 years of age, 16% had symptomatic knee OA
and 10% had symptomatic hip OA [12,13]. The preva-
lence of symptomatic hand OA in the Framingham OA
study was 16% and 8% for women and men, respectively
[14]. With an aging population and the current epidemic
of obesity, a strong risk factor for OA [15], the OA preva-
lence is expected to increase in the coming years [15].
OA has traditionally been defined on the basis of
radiographic features only, or on a combination of radio-
graphic features and joint symptoms [11]. A number of
clinical criteria and radiographic classification systems
have been established to promote uniformity in the
reporting of OA definitions (i.e. The American College
of Rheumatology (ACR) criteria [16-18], the Kellgren-
Lawrence scale [19], and the Osteoarthritis Research
Society International (OARSI) score [20]). Recently, a
distinction between structural joint changes (‘OA dis-
ease’) and individuals’ self-reported symptoms of OA
(‘OA illness’) was recommended for treatment effect
evaluations, which may also be useful in trial design
and recruitment [21].
Self-reported OA is sometimes used as a practical al-
ternative in gaining epidemiological knowledge about
OA, and self-reported physician diagnosed arthritis was
found to be the question with the highest accuracy in
prediction of radiologically confirmed OA [22]. The as-
sociation between the prevalence of self-reported OA
and the prevalence of criteria-based diagnoses of OA
has been investigated to a limited degree for hip and
knee [23-28], but not for hand OA. Although self-
reported OA fails to reach complete accuracy, previous
studies have found satisfactory sensitivity and specificity
and recommend this approach as a screening tool in
large population-based studies [23,26-28]. However,
conflicting results have also been published [25], and for
complete ascertainment procedure in clinical trials, a
clinical examination and radiographs may still remain
necessary [27].
Imaging modalities
While late-stage OA is often characterised by both de-
monstrable structural changes (loss of joint space, os-
teophytes and changes in the subchondral bone) and
patient-reported joint pain, stiffness and disability, there
are only weak correlations between symptoms and OA
pathology, particularly in early stages of the disease [21].
It has been estimated that 40-80% of individuals with
radiographic changes have concurrent symptomatic OA
disease [14,29]. The discrepancy between imaging and
clinical findings is becoming more complex with in-
creased use of sensitive imaging techniques such as
magnetic resonance imaging (MRI), which more fre-
quently demonstrates structural abnormalities, inflamma-
tory changes, and degeneration of soft tissue compared to
conventional radiographs [30]. Most studies using MRI
have included patients with knee OA, showing that bone
marrow lesions and synovitis are associated with pain
[31]. Similar results have been found in hand OA [30,32],
although more studies are needed. Ultrasound also has
the ability to demonstrate both changes in bone and soft
tissue, and a scoring system for use in hand OA has been
developed [33,34], but further work to validate ultrasound
features of OA is needed [35].
Clinically relevant phenotypes
Recently, there has been an interest in classifying OA
populations into different clinical and/or structural phe-
notypes, which might improve the understanding of the
disease and allow the treatment to become more tar-
geted and tailored. A proposal for differentiation of
clinical phenotypes based on age and primary causative
features has been published [15]. Further, cluster ana-
lyses using data from knee OA participants in the Osteo-
arthritis Initiative Study have been performed to identify
phenotypes with different clinical outcomes [36]. More
research on classifications of different phenotypes may
further improve the development within diagnosis, treat-
ment, and monitoring of the OA disease.
Hand OA
Hand photography is an easy and inexpensive imaging
method involving no harm for the subjects. A standar-
dised procedure for taking digital hand photographs, a
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set of reference photographs, and standardised reading
procedure for diagnosing hand OA has been published
showing adequate inter- and intraobserver variation
[37]. However, the diagnostic value of hand photography
in hand OA needs further investigation. The importance
of measuring aesthetic damage in individuals with hand
OA has been recognised [38,39]. The extent to which
deformities in affected joints may have a negative in-
fluence on individuals’ social life has not been syste-
matically assessed. The relation between hand OA and
hypermobility is scarcely investigated, and previous re-
search has shown conflicting evidence [9]. More insight
into this association would be interesting in order to
provide preventive strategies. Obesity has been shown to
be an important risk factor for OA, especially for knee
OA [2] and for total hip replacement [40,41], but there
is now also increasing evidence suggesting a relationship
between obesity and hand OA [9]. Whether OA is part
of a “metabolic syndrome” including overweight, hyper-
tension, and diabetes is being debated and needs further
examination. Affection of the carpometacarpal joint in
the thumb may compromise function in the whole hand,
and was found to contribute more to pain and disability
than affection of the interphalangeal joints [42]. More
research on factors associated with OA in the carpo-
metacarpal joint in the thumb is needed.
Cardiovascular morbidity
Recently, there has been substantial interest in the re-
lationship between various arthritic disorders in rela-
tion to cardiovascular morbidity [43]. Some studies have
shown an association between OA and cardiovascular
morbidity and mortality [44], and it has been suggested
that atherosclerosis may contribute to the initiation or
progression of OA [45,46]. An association between arte-
rial stiffness and hand OA has been found, but the sig-
nificant individual relationship was largely attributable
to the confounding effect of age [43]. These findings and
novel hypotheses need to be explored in longitudinal
studies.
Quality of care
Several international recommendations and standards of
care for OA management have been developed [2,47-51].
However, there has been limited focus on evaluation of
the quality of care provided for OA patients, and previous
studies have revealed low adherence with published rec-
ommendations [52-54], and have suggested that OA care
was suboptimal [55-58]. An English study by Steel et al.
showed that the pass rate for quality indicators on OA
management was only 29% [59], and we expect that the
situation in Norway is similar. The only Norwegian study
in this area is a prospective study on physiotherapy per-
formance in patients with knee OA, in which the authors
concluded that there is a need to promote high quality
evidence into physiotherapy practice [60].
Sick leave and health care utilisation
In Sweden, it was reported that individuals with knee
OA have close to twofold increased risk of sick leave
and about 40-50% increased risk of disability pension
compared to the general population [61]. It is unknown
whether similar figures can be found in Norway. The
costs of OA care will be heavily influenced by the trends
in OA occurrence, the severity of the disease, and the
consequences of OA in function and work ability. More
research is warranted on utilisation of self-management
and treatment in primary, secondary, or tertiary care.
Physical activity
At least 30 minutes physical activity per day for at least
3 days a week is recommended as a general guideline for
those with knee and hip OA [62]. Knowledge on type
and level of physical activity in individuals with OA is
limited. A large survey conducted in the US indicated
that those with OA were less active than healthy individ-
uals [63], but the activity level according to affected joint
was not investigated. A recent US study showed that only
13% of men and 8% of women with knee OA met the
aerobic component of the 2008 Physical Activity Guide-
lines for Americans (≥150 minutes/week of moderate-
to-vigorous–intensity activity lasting ≥10 minutes) [64]. A
recent Norwegian study with accelerometer-determined
physical activity revealed that only one in five adults or
older people met the current national physical activity rec-
ommendations to accumulate at least 30 minutes of daily
moderate intensity physical activity [65]. The study also
showed that overweight and obese participants performed
less overall physical activity compared to normal weight
participants [66]. However, knowledge of physical activity
levels in Norwegian individuals with OA is needed.
The purpose of this study
This study has been designed to recruit individuals from
an unselected adult population to gain more knowledge
about clinically and radiologically confirmed OA, risk
factors, consequences, and management of OA. The
study incorporates different imaging techniques (con-
ventional radiographs, MRI, and US), patient-reported
outcomes and performance-based outcome measures,
cardiovascular morbidity and metabolic syndrome in
individuals with hand, hip and/or knee OA. Such data
will be valuable for various epidemiological and clini-
cal studies.
The main aims of the present study are to evaluate:
1. The prevalence of hand, hip, and knee OA in a
population-based cohort.
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2. The association between structural abnormalities
(conventional radiographs, MRI and US) and
symptoms in individuals with hand, hip, and
knee OA.
3. The concordance between OA features in the hip
and knee joints identified by conventional
radiographs and US examination.
4. The associations between different OA phenotype
classifications and clinical outcomes.
5. The associations between cardiovascular morbidity
as well as vascular biomarkers and OA phenotypes.
6. The associations between OA in the
carpometacarpal joint in the thumb and
self-reported symptoms and function.
7. The frequency of self-reported concerns related to
aesthetic damage in the joints of the hand and of
self-reported participation restrictions due to
aesthetic damage.
8. Obesity as a risk factor for hand OA, and
associations between different OA locations and
medical conditions in a metabolic syndrome
(defined as overweight, hypertension, and diabetic
disease).
9. The quality of OA care, health care utilisation, and
sickness absence among those with hand, hip, and
knee OA.
10. The association between self-reported physical
activity, function, and pain in individuals with hand,
hip, and knee OA.
Methods/Design
Design and setting
The MUST has been designed as an observational study
which includes a population-based postal survey (Q1) as
well as a subsample (the MUST OA cohort) who attend
a comprehensive clinical examination (CE) and complete
OA specific questionnaires (Q2 and Q3).
The target population for the postal population-based
survey is the inhabitants in the Ullensaker Municipality,
which is a rural community 40 kilometres northeast of
Oslo. Some of the nearly 30 000 inhabitants commute to
Oslo for work, but for the last 10 to 15 years, the work
opportunities and the number of Ullensaker inhabitants
have expanded due to the building and the subse-
quent management related to the national Oslo Air-
port Gardermoen. This development has resulted in
some minor changes in demographic factors, as many
persons of younger age and with higher education
levels have moved into the municipality.
Participants in the population-based survey
All inhabitants aged between 40 and 79 years receive
the postal four page questionnaire (Q1). Information on
residence is provided by the Population Register. The
questionnaire is returned by mail in a pre-paid envelope.
One written reminder is sent to non-responders after
eight weeks.
Participants in the comprehensive clinical examination
Individuals eligible for the comprehensive clinical exam-
ination are identified using the self-reported OA item in
the population-based postal survey (Q1): ‘Have you ever
been diagnosed with osteoarthritis in hip/knee/hand by
a medical doctor and/or x-ray?’ Response categories in-
clude: Yes, hip/ Yes, knee/ Yes, hand/ No. Those who
self-report OA in their hip, knee, and/or hand, will re-
ceive a postal request to attend a clinical examination
(CE) performed at Diakonhjemmet Hospital, Oslo. Two
written reminders are sent to non-responders. The par-
ticipants are screened for clinical examination eligibility
by the project coordinator, and those who are unable to
walk (with or without walking aids) and/or do not speak
or understand Norwegian language are excluded for the
clinical examination.
Assessments
The population-based postal survey questionnaire (Q1)
The four-page questionnaire includes demographic ques-
tions as well as questions about life style, general health,
musculoskeletal pain, OA, comorbidities, health care uti-
lisation, medication use, and functional ability [67-70].
The questionnaire includes items on self-reported cardio-
vascular disease and symptoms (Table 1).
The OA specific questionnaire (Q2)
Participants who are eligible and scheduled for the cli-
nical examination fill in the OA specific questionnaire
(Q2) at home before attending the clinical examination.
This questionnaire includes standardised instruments
targeting health related quality of life, physical activity,
cardiovascular disease questions, and OA disease specific
instruments [71-79] (Table 2).
The comprehensive clinical examination (CE)
The comprehensive clinical examinations are scheduled
on a weekly basis with eight or nine participants at any
one session. These examinations are performed by phy-
sicians and health professionals in the project group,
radiographers at Diakonhjemmet Hospital, and trained
medical students. The clinical examination lasts for
about four hours; transportation time not included. Be-
forehand, the participants receive a postal, OA specific
questionnaire (Q2) to fill in at home (Table 2). They an-
swer some additional questions on pain and OA symp-
toms (Q3) during the clinical examination (Table 3). The
clinical examination (CE) includes a wide array of assess-
ments (Table 4):
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Table 1 The population-based postal survey questionnaire (Q1)
Measure Measurement scale
Demographic variables
Gender Female/male
Age Birth year
Marital status Married, cohabitating/Separated, divorced/Widowed/single
Body height Centimetres
Body weight Kilograms
Employment status Working full time/working part time/not working/student/
working full time in the home/unemployed or seeking work/
age retired/disability pension/sick leave
Education Lower secondary school/ Higher secondary school/University
1-4 years/University >4 years
Lifestyle variables
Frequency of leisure time physical activity [67] Never/Less than once a week/Once a week/2-3 times a week/
Almost every day
Intensity of leisure time physical activity [67] I take it easy without breaking into sweat or losing my breath/
I push myself so hard that I lose my breath and break into a sweat/
I push myself to near-exhaustion
Duration of leisure time physical activity [67] Less than 15 minutes/16-30 minutes/30 minutes-1 hour/More
than 1 hour
Daily smoking Yes/no
Musculoskeletal pain and symptoms
Standardised Nordic Questionnaire (SNQ) Pain in past year [68] Body manikin showing 10 body parts: Yes/No
SNQ Pain affected daily activities [68] Body manikin showing 10 body parts: Yes/No
SNQ Pain in past 7 days [68] Body manikin showing 10 body parts: Yes/No
Average musculoskeletal pain past 7 days NRS: 0-10
Osteoarthritis diagnosis ‘Have you ever been diagnosed with osteoarthritis in hip/knee/
hand by a medical doctor and/or x-ray?’ Response categories
include: Yes, hip/ Yes, knee/ Yes, hand/ No.
Most troublesome OA joint Knee/Hip/Hand
Health, comorbidity, and subjective health complaints
General health nowadays Poor/Not so good/Good/Very Good
Heart disease Yes/No
Lung disease Yes/No
Cancer Yes/No
Diabetes Yes/No
Osteoporosis Yes/No
Irregular heartbeat Yes/No
Chest pain Yes/No
Breathing difficulties Yes/No
Gastrointestinal symptoms Yes/No
Skin problems Yes/No
Tiredness/fatigue Yes/No
Dizziness Yes/No
Anxiety Yes/No
Depression Yes/No
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1) The medical assessment.
The medical assessments are performed by a
medical doctor (BSC) with many years of clinical
experience in rheumatology and by trained final-year
medical students under supervision of BSC. The
medical assessment will include an assessment of
clinical signs of OA as well as knee joint effusion
using the Stroke test [80]. Verification of the ACR
criteria for hip, knee and hand OA are performed
[16-18]. The medical doctor also scores ‘The Doctor
Global assessment of OA disease’, and asks when the
participants were diagnosed with OA and when they
first experienced OA symptoms. Further, the doctor
investigates familial OA, dominant hand and foot,
and registers current (and former) employment
status according to level 0-5 on the Tegner Activity
Scale [81].
2) Conventional radiographs.
Bilateral radiographs of the hand, hip, and knee
joints are performed on all participants at the
Diakonhjemmet Hospital according to a
standardised protocol. Hand: Posterior-anterior
projection of hands. Hip: Supine lying with a
calibration bullet between the thighs. Anterior-
posterior projection of the total pelvic frontal view.
Knee: The procedure is performed using the
SynaFlexer™ frame which standardises knee flexion
angle to 20° and external foot rotation to 5°, as
described by Kothari et al. [82]. In this protocol, a
10° caudal beam angulation ensures alignment of the
beam with the medial tibial plateau (fluoroscopy).
X-ray views include anterior-posterior, lateral, and
patella tangential. The radiographs are scored
according to the Kellgren and Lawrence (KL) scale
[19] and the OARSI atlas [20].
3) Magnetic resonance imaging (MRI) of the dominant
hand.
MRI with gadolinium contrast enhancement is
performed according to a standardised protocol at
the Diakonhjemmet Hospital on the dominant hand
in participants with self-reported hand OA in the
population-based postal survey (Q1) and without
contraindications for MRI examination. A highfield
(1.0T) extremity MRI unit (ONI; GE Healthcare,
Waukesha, Wisconsin, USA) is used to examine the
second to fifth proximal interphalangeal (PIP) and
distal interphalangeal (DIP) joints. The acquisition,
MRI sequences, and scoring of MRI features
(The Oslo Hand Osteoarthritis MRI score) have
previously been described [83].
4) Ultrasound.
Two trained and experienced medical students
perform the bilateral ultrasound examination of the
hand, hip, and knee joints of all participants with
Table 1 The population-based postal survey questionnaire (Q1) (Continued)
Health care utilization
Medical doctor Number of visits past year
Medical specialist Number of visits past year
Physiotherapist Number of visits past year
Chiropractor Number of visits past year
Occupational therapist Number of visits past year
Home nurse Number of visits past year
Alternative therapy Number of visits past year
Hospital admissions Number of days past year
Medication use
Glucosamine Yes, daily/Yes, sometimes/No
Paracetamol Yes, daily/Yes, sometimes/No
Anti-inflammatory medication Yes, daily/Yes, sometimes/No
Use this medication due to musculoskeletal pain Yes, daily/Yes, sometimes/No/Do not know
Functional ability
10-ADL Multidimensional Health Assessment Questionnaire
(MDHAQ) [69]
0-40; Without any difficulty/With some difficulty/With much
difficulty/Unable to do
COOP/WONCA Physical fitness [70] Very heavy activity/Heavy /Moderate/ Light/Very light
COOP/WONCA Feelings [70] Not at all/Slightly/Moderately/Quite a bit/Extremely
COOP/WONCA Daily activities [70] No difficulty at all/A little bit of difficulty/Some difficulty/Much
difficulty/Could not do
COOP/WONCA Social activities [70] Not at all/Slightly/Moderately/Quite a bit/Extremely
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Table 2 Measures in the OA specific questionnaire (Q2)
Measure Measurement scale
Quality of life
SF-36 Vitality [71] 0-100
SF-36 Physical functioning [71] 0-100
SF-36 Bodily pain [71] 0-100
SF-36 General health perceptions [71] 0-100
SF-36 Physical role functioning [71] 0-100
SF-36 Emotional role functioning [71] 0-100
SF-36 Social role functioning [71] 0-100
SF-36 Mental health [71] 0-100
EuroQol EQ-5D [72] (-0.59-1)
Physical activity
International Physical Activity Questionnaire (IPAQ) vigorous-intensity activity [73] Mean minutes/week, MET-minutes/week
IPAQ moderate-intensity activity [73] Mean minutes/week, MET-minutes/week
IPAQ walking [73] Mean minutes/week, MET-minutes/week
IPAQ sitting [73] Mean minutes/week, MET-minutes/week
Physical activity with increased heart rate and breathing for at least 30 min 1-5; 3 times a week/1-2 times a week/1-2 times a month/Do not
do regular physical activity/Unable to do due to reduced physical
functioning
Osteoarthritis specific questionnaires
Knee injury and Osteoarthritis Outcome Score (KOOS) pain [74] 0-40 or 0-100 (normalised score)
KOOS symptoms [74] 0-20 or 0-100
KOOS ADL [74] 0-68 or 0-100
KOOS Sport/Rec [74] 0-16 or 0-100
KOOS QOL [74] 0-16 or 0-100
Hip disability and Osteoarthritis Outcome Score (HOOS) pain [75] 0-36 or 0-100
HOOS symptoms [75] 0-28 or 0-100
HOOS ADL [75] 0-68 or 0-100
HOOS Sport/Rec [75] 0-16 or 0-100
HOOS QOL [75] 0-16 or 0-100
Australian/Canadian Osteoarthritis Hand Index (AUSCAN) pain [76] 0-20
AUSCAN stiffness [76] 0-4
AUSCAN function [76] 0-36
AUSCAN total [76] 0-60
Functional Index for Hand Osteoarthritis (FIHOA) [77] 0-30
Michigan Hand Outcomes Questionnaire (MHOQ) aesthetics [78] 0-40
Patient-reported quality of osteoarthritis care
OsteoArthritis Quality Indicator (OA-QI) questionnaire [79] Yes/No/Do not remember, not overweight, no such problems,
no pain/discomfort, not severely troubled
Cardiovascular sypmtoms/disease
Paroxystic atrial fibrillation, chronic atrial fibrillation, heart failure, dyspnea,
peripheral edema, angina pectoris, chest pain (description, location, time points,
frequency, duration), use of nitroglycerine, acute myocardial infarction (AMI), heart
surgery (percutaneus coronary intervention (PCI), coronary artery bypass grafting
(CABG), heart valve replacement), peripheral vascular disease, cerebral
haemorrhage, cerebral infarction, transitory ischemic attach (TIA), diphtheria,
scarlet fever, rheumatic fever, family history of premature cardiovascular disease in
first degree relatives, age at heart infarction, sudden death in family for unknown
reason
Yes/No
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supervision from an experienced sonographer/
rheumatologist (HBH). A linear array transducer is
used (5–13 MHz, Siemens Antares, Sonoline;
Siemens Medical Solutions, Mountain View,
California, USA) with fixed settings of the machine.
To ensure standardisation, the same ultrasound
machine without software upgrading is used
throughout the study.
Hand: The participants sit with hands resting on a
small table. Osteophytes are defined as cortical
protrusions, and the presence of osteophytes is
scored on a 0-3 scale as previously described [34].
In each finger joint the proximal and distal part
are assessed as a whole, and the largest osteophyte
determines the score independently of the number
and location of other osteophytes in the same
joint. The sonographers score osteophytes in the
following 15 joints bilaterally (standard scanning
projections): carpometacarpal (CMC) 1 (radio-
palmar), metacarpophalangeal (MCP) 1–5 (dorsal),
PIP 1–5 (dorsal) and DIP 2–5 (dorsal). Each joint
is scanned longitudinally from the radial to the
ulnar side, and transverse scanning is performed if
there is uncertainty about the presence of
pathology. In addition, scoring of synovitis (B-
mode) and vascularity (power Doppler) (both on
0-3 scales) are performed according to previous
descriptions [84].
Hip: The participants lie in supine position. The
sonographers score the size of osteophytes at the
femoral neck (score 0-3), measure the maximal
capsule thickness at the femoral neck as well as
evaluate the form of the capsule and the shape of
the femoral head. In addition, the participants are
asked about groin pain during the last week.
Knee: The participants lie in supine position with
the knee extended for scoring of osteophyte sizes
at the medial and lateral joint space (0-3 scale). In
addition, meniscus protrusion medially and
laterally is recorded, and the degree of synovitis in
the suprapatellar recess is scored [84]. With the
knee flexed to 90°, the thickness of the cartilage at
the distal femur is measured in millimetres at the
sulcus as well as at the lateral and medial condyle.
Additionally, the cartilage quality at the distal
femur is evaluated, and the presence of calcium
crystal pyrophosphate deposition (CPPD) changes
are recorded. All participants are asked about knee
pain during the last week.
5) Functional assessment.
Physiotherapists perform the following functional
assessments according to standardised protocols:
Moberg Pick Up Test [85], 6 minute Walk Test [86],
and 30 second Timed Stand Test [87].
Hypermobility is assessed using the Beighton scale
Table 2 Measures in the OA specific questionnaire (Q2) (Continued)
Other diseases
High blood pressure (or antihypertensive treatment), diabetes, metabolic disease,
kidney disease, hepatic disease, gastric ulcer, ulcerous colitis, Crohn's disease,
deep vein thrombosis, lung embolia, iridocyclitis
Yes/No
Immunological diseases
List any other immunological disease (e.g rheumatoid arthritis, ankylosing
spondylitis, psoriasis, psoriatic arthritis, Sjøgren's disease, polymyalgia rheumatica,
systemic lupus erythematosus (SLE), Lichen ruber, vitiligo etc)
List of comorbidity
List all current medication use Medication list
Other
Smoking Never/Daily/stopped smoking more than 6 months ago
Alcohol use Daily/Weekly/Monthly/Never
Age at menopause Age
Oestrogen use Yes/no
Previous use of contraception pills Yes/no
Number of children Number
Table 3 Questions to complete during the clinical
examination (Q3)
Measure Measurement scale
Pain/stiffness in or around the joint on most
days in the precious month
Yes/No
Average joint pain the past week NRS: 0-10
Which joint most painful Hip/Knee/Hand
Fatigue past week NRS: 0-10
Patient global assessment of the OA disease NRS: 0-10
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Table 4 Measures included in the comprehensive clinical examination (CE)
Measure Measurement scale
Medical examination
Lenght of time with OA disease Year of OA diagnosis
Lenght of time with OA symptoms Year when first experienced OA symptoms
Dominant hand Right/left
Dominant leg Right/left
Father with OA Yes/No
Mother with OA Yes/No
Siblings with OA Yes/No
Tegner activity scale [81] 0-5
Stroke test [80] 0-3
Soft tissue swelling joint count (SJC) Shoulder, acromioclavicular (AC), elbow, wrist, CMC, MCP, PIP, DIP, hip, knee,
ankle, metatarsophalangeal (MTP); Yes/No
Bony enlargement joint count (BEJC) Shoulder, AC, elbow, wrist, CMC, MCP, PIP, DIP, hip, knee, ankle, MTP; Yes/No
Tender joint count (TJC) Shoulder, AC, elbow, wrist, CMC, MCP, PIP, DIP, hip, knee, ankle, MTP+
cervical columna, thoracal columna, lumbal colulma; Yes/No
Limited motion joint count (LMJC) Shoulder, AC, elbow, wrist, CMC, MCP, PIP, DIP, hip, knee, ankle, MTP+
cervical columna, thoracal columna, lumbal colulma; Yes/No
ACR classification criteria for hip OA [17] Hip pain AND at least 2 of the following 3 features: erythrocyte
sedimentation rate (ESR) <20mm/hour, radiographic femoral or acetabular
osteophytes, radiographic joint space narrowing
ACR clinical classification criteria for knee OA [16] Knee pain AND at least 3 of 6 of the following features: age > 50, stiffness <
30 min, crepitus, bony tenderness, bony enlargement, no palpable warmth
ACR classification criteria for hand OA [18] Hand pain, aching or stiffness AND 3 or 5 of the following features: hard
tissue enlargement of ≥2 of 10 selected joints, hard tissue enlargement of ≥2
DIP joints, fewer than 3 swollen MCP joints, deformity of ≥1 of 10 selected
joints (bilateral 2nd-3rd DIP, 2nd-3rd PIP, and 1st CMC)
Doctor global assessment of OA disease NRS: 0-10
Physical function examination
Range of movement Hip: flexion, extension, abduction, internal rotation, external rotation
Knee: flexion, extension
Beighton scale [88] 0-9
Maximum grip strenght (JAMAR dynamometer) Kilograms (mean of 3 repetitions)
Moberg Pick Up Test [85] Seconds (Left/Right hand)
30 sec Timed Stand Stands [87] Number of stands
6 Minutes Walk Test [86] Meters
Leg pain during 6 Minutes Walk Test Yes/No + NRS: 0-10
Imaging
Magnetic resonance imaging Synovitis grade 0-3, flexor tenosynovitis grade 0-3, erosion grade 0-3, cyst
absent/present, osteophyte grade 0-3, joint space narrowing grade 0-3,
malalignment absent/present, bone marrow lesion grade 0-3, collateral
ligament pathology absent/present (the Oslo hand OA MRI score)
Dominant hand (only when self-reported hand OA)
Conventional radiographs
Hip joints, bilateral Millimetre joint space width
Knee joints, bilateral Kellgren and Lawrence scale: grade 0-4
OARSI: medial and lateral femoral condyle/medial and lateral tibial plateau
osteophyte grade 0-3+, medial and lateral compartment joint space
narrowing grade 0-3+, medial tibial attrition absent/present, medial tibial
sclerosis absent/present, lateral femoral sclerosis absent/present
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Table 4 Measures included in the comprehensive clinical examination (CE) (Continued)
Hand joints, bilateral Kellgren and Lawrence scale: grade 0-4
OARSI: osteophyte grade 0-3, joint space narrowing grade 0-3, malalignment
absent/present, erosion absent/present sclerosis absent/present, cyst absent/
present
Ultrasound
HIP joint osteophytes 0, none; 1, minor; 2, moderate; 3, major size of osteophytes
Capsule diameter caput Millimetre
Capsule diameter collum Millimetre
Capsule shape 0, concave; 1, flat; 2, convex
Caput femoris shape 0, normal; 1, minor flattening; 2, considerably changed shape
Groin pain last week 0, no pain; 1, some pain; 2, moderate pain; 3, severe pain
KNEE joint osteophytes, femur medial and lateral 0, none; 1, minor; 2, moderate; 3, major size of osteophytes
Knee joint osteophytes, tibia medial and lateral 0, none; 1, minor; 2, moderate; 3, major size of osteophytes
Lateral and medial menisci protrusion 0, none; 1, minor; 2, major
Synovitis in the suprapatellar recess (combined synovitis and effusion) 0, none; 1, minor; 2, moderate; 3, major
Femur cartilage height at sulcus, lateral, and medial condyle Milimeter
Femur cartilage quality, Degree of hyperechogenisity 0, normal; 1 minor; 2 major
Femur hyaline cartilage, Calcium crystal pyrophosphate deposition
(CPPD)
0, none; 1, presence of CPPD changes
Kne pain last week 0, no pain; 1, some pain; 2, moderate pain; 3, severe pain
HAND joint osteophytes 30 joints: 0, none; 1, minor; 2, moderate; 3, major size of osteophytes
Hand joint synovitis (combined synovitis and effusion) 30 joints: 0, none; 1, minor; 2, moderate; 3, major
Hand joint vascularity 30 joints: 0, none; 1, minor (1-2 small vessels); 2, moderate; 3, major
Cardiovascular examination
Heart rate Beats per minute
Systolic blood pressure (monitor) mmHg
Diastolic blood pressure (monitor) mmHg
Ankle brachial index (ABI) Systolic blood pressure leg (mmHg)/ Systolic blood pressure arm (mmHg)
Arterial stiffness Pulse wave velocity, augmentation index
ECG Electrocardiogram
Surgery/injuries
Hip prosthesis Yes/No; Right/Left; Year of surgery
Hip surgery/injury Yes/No; Right/Left; Type surgery/injury; Type treatment; MD/Hospital
Knee prosthesis Yes/No; Right/Left; Year of surgery
Knee surgery/injury Yes/No; Right/Left; Type surgery/injury; Type treatment; MD/Hospital
Hand surgery/injury Yes/No; Right/Left; Type surgery/injury; Type treatment; MD/Hospital
Hand synovectomy Yes/No; Number of operations
Hand joint prosthesis Yes/No; Number of operations
Hand joint fusion Yes/No; Number of operations
Other operations on hand joints or tendons Yes/No; Number of operations
Anthropometric data
Body weight Centimeters
Body height Kilograms
Hip circumference Centimeters
Waist circumference Centimeters
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[88], and maximal grip strength is measured using
Jamar Dynamometer. The passive range of motion
of the hip and knee joints is examined in supine and
prone positions with the use of fixation belts.
6) Cardiovascular assessment.
Trained medical students perform the
cardiovascular assessments after instructions from
two experienced researchers in cardiovascular
medicine (SP and AGS). Brachial blood pressure
(BP) and heart rate are measured using an Omron
M7 after a minimum 5 minute rest in a supine
position in a quiet room. Repeated measurements
are performed until two of the measurements have a
≤ 5 mmHg difference in both systolic and diastolic
pressures, and a mean is calculated. A 12-lead
electrocardiogram (ECG) is recorded digitally in this
setting. The ankle-brachial index (ABI) is computed
in the standardised fashion [89]. The systolic
pressure is estimated by a Sonotrax - Pocket
Doppler Vascular - 8MHz probe in the posterior
tibial and dorsalis pedis arteries in both legs. The
highest of these distal pressures is divided by the
brachial systolic pressure to obtain the ABI. Due to
time limitations the ABI is performed in every
second individual.
Pulse wave analysis (PWA) using the Sphygmocor
apparatus (Atcor Australia) is performed to estimate
the pulse wave velocity (PWV) and augmentation
index (AIx). We have chosen to estimate the
carotid-femoral PWV (cfPWV) between the sites on
the carotid and on the femoral artery where the
pulse is most strongly palpated. The start of the
pressure waves at the carotid and femoral artery are
ECG gated to adjust for transit time. The PWV is
calculated from knowing both the transit-time for
the pulse wave travelling from the heart to the two
sites and the distance between these sites [90]. The
AIx is defined as the change in pressure between the
second and first systolic peaks as a percentage of the
pulse pressure and is standardised to a heart rate of
75. AIx is calculated by applying a validated transfer
system to pressure recordings of the arterial
pressure waves at the radial artery [91]. Individuals
suffering from atrial fibrillation are excluded from
the PWA analysis. Based on prior studies, the
participants are requested to abstain from food,
drinks (except for water), and smoking for at least 3
hours prior to the PWA examinations [90].
7) Body weight and height, hip and waist
circumference, and digital photo of hands.
The weight and height are measured on all
participants with shoes removed and pockets
emptied. The hip circumference is measured using a
tape measure around the maximum circumference,
and waist circumference is measured at the
narrowest waist after relaxed exhalation. A
standardised digital photo from above, with both
hands on top of a black fabric on a small tray, is
taken by the medical student performing the
ultrasound examination.
8) Blood and urine sample.
Blood (full blood and sera) and urine samples are
collected and stored in a biobank for future analyses
of associations between clinical characteristics and
biomarkers or candidate genes. Blood samples are
analysed for haemoglobin and erythrocyte
sedimentation rate at the hospital laboratory.
Data from a previous study in Ullensaker Municipality
The Ullensaker Study is a population based epidemio-
logical cohort study with musculoskeletal pain as the
primary focus and with three preceding surveys conduc-
ted in 1990, 1994, and 2004 [92-95]. The surveys were
sent to all inhabitants in the Ullensaker Municipality in
the following birth cohorts: 1918-20, 1928-30, 1938-40,
1948-50, 1958-60, 1968-70, and 1978-80 (only in 2004).
Hence, for a subsample, we will be able to merge data to
the previously collected data in The Ullensaker Study on
musculoskeletal pain and functional ability in addition
to demographic factors, body height and weight, comor-
bidity, mental distress, sleep, sick leave, health care uti-
lisation, and physical activity. We will investigate if any
of these previous data can be identified as predictors of
incident OA.
Data from other sources
Along with the initial postal questionnaire, the partici-
pants are asked for consents to merge the data to na-
tional data registries (e.g. The Norwegian Arthroplasty
Register, The register of The Norwegian Labour and
Table 4 Measures included in the comprehensive clinical examination (CE) (Continued)
Digital photo of hands Standardised photo from above, both hands on top of a black fabric on a
small tray
Biological samples
Blood haemoglobin g/dL
Blood erythrocyte sedimentation rate (ESR) mm/h, whole blood and blood serum are stored in a biobank
Urine Are stored in a biobank
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Welfare Administration, The Norwegian Prescription
Database, The Medical Birth Registry of Norway, The
Cancer Registry of Norway, and The Norwegian Cause
of Death Registry). Furthermore, those who have previ-
ously participated in Ullensaker Study are asked for per-
mission to merge with the data collected in 1990, 1994,
and/or 2004.
Project timeline
In order to avoid a large time lag between the initial
population-based postal survey questionnaire (Q1) and
the subsequent clinical examination (Q2 and CE), the
Q1 questionnaire are sent in three dispatches to allow
time for the clinical examinations in the interim (Figure 1).
Dispatch no.1 targets inhabitants with birth year ending in
1, 2, or 3 with the questionnaires being sent by mail in
March 2010. The next dispatch approaches the previous
Ullensaker Study participants (birth years ending in 8,
9, or 0) and is mailed in November 2010, which is the
same time of the year as the three preceding surveys.
The questionnaires for the third dispatch are sent in
September 2011 to inhabitants with birth years ending
in 4, 5, 6, or 7. We estimate that the clinical exami-
nation for the third dispatch will be completed in the
spring 2013.
Statistical analyses
Parametric and non-parametric statistical analysis mo-
dels will be used depending on the distribution of the
variables.
Figure 1 Study timeline.
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Sample size
The response rates in the preceding Ullensaker Study
surveys decreased from 67% in 1990, to 63% and 55%
in 1994 and 2004, respectively. The results from 2004
showed an overall self-reported OA prevalence of 12.8%
in the total sample aged 25 to 75 years [10]. In January
2010, the total population in Ullensaker Municipality was
approximately 29 000 persons, and our estimations sug-
gested that the target adult population is about 12 000
persons.
Ethical aspects
The study was approved by the Norwegian Regional
Committee for Medical and Health Research Ethics
(Ref.no: 2009/812a (population-based survey question-
naire (Q1)) and 2009/1703a (OA specific questionnaires
and clinical examination (CE, Q2 and Q3)) and the
Norwegian Data Protection Authority. The study sample
receives written information about the study, and sepa-
rate written consents are given for the initial baseline
questionnaire and for the clinical examination.
Discussion
This population-based observational study will provide
important knowledge about the prevalence of sympto-
matic and radiographically confirmed OA, risk factors,
consequences of OA, comorbidity in persons with OA,
and quality of OA care in Norway. Outcomes may be
linked to prevalence estimates of study sample subsets
according to radiographic classification of OA severity,
as has previously been performed with rheumatoid arth-
ritis [96].
A major advantage in this study is the opportunity to
merge the data with other data sources. Data will be
merged with data from the previous Ullensaker study,
national registries, and with the data from the com-
prehensive clinical examination, which include several
imaging techniques, patient-reported outcome measure-
ments, performance-based tests, cardiovascular morbi-
dity, and data on metabolic syndrome. Hence, a wide
spectre of analyses may be done on the merged data.
Furthermore, more research on the association between
self-reported hand, hip, and knee OA and clinically or
radiologically confirmed OA will provide valuable know-
ledge for future epidemiological studies on OA.
The value of population-based studies is however re-
lated to the response rate. In the previous Ullensaker
Study surveys the response rate has shown to decrease
over time, which is in line with other populations studies
showing a decrease in participation rates during the past
three to four decades [97]. Whether a poor participation
rate will be a problem, is related to the representativeness
of the participants since low participation can provide
more opportunity for bias to occur. Our opportunities to
explore potential selection bias are limited, but we will be
able to compare participants and non-participants in rela-
tion to age and gender as well as compare participants
with regional or national mean frequencies for other
demographic factors (i.e. marital status, education, and
employment status).
There are plans for future follow-up surveys for the
MUST participants and clinical examinations of the
MUST OA cohort, which will provide further knowledge
about various factors, for example about trends in OA
prevalence, prognosis according to functional ability,
quality of care in health services, and health care utilisa-
tion. Hence, this population-based observational study
will constitute a unique platform with a large potential
for future OA research by providing valuable opportun-
ities for various epidemiological and clinical studies on
OA in Norway.
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